JP2016517306A - センサシステム - Google Patents
センサシステム Download PDFInfo
- Publication number
- JP2016517306A JP2016517306A JP2016501210A JP2016501210A JP2016517306A JP 2016517306 A JP2016517306 A JP 2016517306A JP 2016501210 A JP2016501210 A JP 2016501210A JP 2016501210 A JP2016501210 A JP 2016501210A JP 2016517306 A JP2016517306 A JP 2016517306A
- Authority
- JP
- Japan
- Prior art keywords
- sensor
- hydrogel
- magnetic
- catheter
- sheath
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000758 substrate Substances 0.000 claims abstract description 19
- 238000004891 communication Methods 0.000 claims abstract description 7
- 239000000017 hydrogel Substances 0.000 claims description 157
- 230000005291 magnetic effect Effects 0.000 claims description 69
- 239000006249 magnetic particle Substances 0.000 claims description 45
- 239000012491 analyte Substances 0.000 claims description 38
- 239000002122 magnetic nanoparticle Substances 0.000 claims description 12
- 239000000560 biocompatible material Substances 0.000 claims description 5
- 239000010410 layer Substances 0.000 claims 1
- 239000002356 single layer Substances 0.000 claims 1
- 108090000190 Thrombin Proteins 0.000 description 23
- 229960004072 thrombin Drugs 0.000 description 23
- 239000002245 particle Substances 0.000 description 21
- 238000000034 method Methods 0.000 description 19
- 230000008859 change Effects 0.000 description 17
- 238000012544 monitoring process Methods 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 108010049003 Fibrinogen Proteins 0.000 description 9
- 102000008946 Fibrinogen Human genes 0.000 description 9
- 230000008901 benefit Effects 0.000 description 9
- 229940012952 fibrinogen Drugs 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 230000027455 binding Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010053567 Coagulopathies Diseases 0.000 description 5
- 230000023555 blood coagulation Effects 0.000 description 5
- 230000035602 clotting Effects 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 4
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 229940127219 anticoagulant drug Drugs 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- 239000003114 blood coagulation factor Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 108091023037 Aptamer Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000007675 cardiac surgery Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005294 ferromagnetic effect Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- -1 polydimethylsiloxane Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 229910000859 α-Fe Inorganic materials 0.000 description 2
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- KUQRLZZWFINMDP-BGNLRFAXSA-N 2-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KUQRLZZWFINMDP-BGNLRFAXSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 108010029697 CD40 Ligand Proteins 0.000 description 1
- 102100032937 CD40 ligand Human genes 0.000 description 1
- 102400000432 CD40 ligand, soluble form Human genes 0.000 description 1
- 101800000267 CD40 ligand, soluble form Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010048554 Endothelial dysfunction Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- YDGMGEXADBMOMJ-LURJTMIESA-N N(g)-dimethylarginine Chemical compound CN(C)C(\N)=N\CCC[C@H](N)C(O)=O YDGMGEXADBMOMJ-LURJTMIESA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- QJVKUMXDEUEQLH-UHFFFAOYSA-N [B].[Fe].[Nd] Chemical compound [B].[Fe].[Nd] QJVKUMXDEUEQLH-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 125000005620 boronic acid group Chemical group 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- KPLQYGBQNPPQGA-UHFFFAOYSA-N cobalt samarium Chemical compound [Co].[Sm] KPLQYGBQNPPQGA-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009429 electrical wiring Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 230000008694 endothelial dysfunction Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007247 enzymatic mechanism Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000005293 ferrimagnetic effect Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000013152 interventional procedure Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 229910001172 neodymium magnet Inorganic materials 0.000 description 1
- 230000008634 non enzymatic mechanism Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000765 poly(2-oxazolines) Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003361 porogen Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229910000938 samarium–cobalt magnet Inorganic materials 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4842—Monitoring progression or stage of a disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
- H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0223—Magnetic field sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0285—Nanoscale sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/06—Arrangements of multiple sensors of different types
- A61B2562/063—Arrangements of multiple sensors of different types in a linear array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/06—Arrangements of multiple sensors of different types
- A61B2562/066—Arrangements of multiple sensors of different types in a matrix array
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Nanotechnology (AREA)
- Power Engineering (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
本出願は2013年3月11日出願の米国仮特許出願番号US61/851、603、2014年1月15日出願の米国仮特許出願番号US61/927、683の優先権を主張するものであり、いずれもその全体が参照により本明細書に援用される。
Claims (21)
- 少なくとも1つのセンサに連結した基板と、
前記少なくとも1つのセンサと通信する電子ユニットと、
を含み、
前記基板は、カテーテルに取り付けられるように構成されていることを特徴とするカテーテル用センサシース。 - 前記少なくとも1つのセンサはヒドロゲルセンサを含む請求項1に記載のカテーテル用センサシース。
- 前記少なくとも1つのセンサは、さらに、前記ヒドロゲルセンサに連結した複数の磁性粒子を含む請求項2に記載のカテーテル用センサシース。
- 前記磁性粒子は磁性ナノ粒子を含む請求項3に記載のカテーテル用センサシース。
- 前記複数の磁性粒子のそれぞれは磁場を有し、前記複数の磁性粒子の前記磁場は同じ方向に配向している請求項3に記載のカテーテル用センサシース。
- 前記複数の磁性粒子のそれぞれは磁場を有し、前記複数の磁性粒子の前記磁場はハルバッハ配列に配向している請求項3に記載のカテーテル用センサシース。
- 前記磁性粒子は前記ヒドロゲルセンサ内に埋め込まれている請求項3に記載のカテーテル用センサシース。
- 前記ヒドロゲルセンサはアナライトに感受性である請求項3に記載のカテーテル用センサシース。
- 前記磁性粒子は前記ヒドロゲルセンサ上の1層である請求項3に記載のカテーテル用センサシース。
- 前記少なくとも1つのセンサは、さらに、前記ヒドロゲルセンサに隣接する磁力計を備える請求項3に記載のカテーテル用センサシース。
- 前記基板は可撓性の生体適合性材料を備え、前記生体適合性材料の少なくとも一部はカテーテルに巻きつけるように湾曲している請求項1に記載のカテーテル用センサシース。
- 少なくとも1つのヒドロゲルセンサに連結した基板と、
前記少なくとも1つのヒドロゲルセンサに隣接した磁力計と、
前記少なくとも1つのヒドロゲルセンサに連結した複数の磁性粒子と、
を含むセンサシステム。 - 前記複数の磁性粒子のそれぞれは磁場を有し、前記複数の磁性粒子の前記磁場は同じ方向に配向している請求項12に記載のセンサシステム。
- 前記複数の磁性粒子のそれぞれは磁場を有し、前記複数の磁性粒子の前記磁場はハルバッハ配列に配向している請求項12に記載のセンサシステム。
- 前記複数の磁性粒子は磁性ナノ粒子を含む請求項12に記載のセンサシステム。
- 前記基板は、カテーテルに取り付けるように構成されたシースを備える請求項12に記載のセンサシステム。
- 前記シースは可撓性の生体適合性材料を備え、前記生体適合性材料の少なくとも一部はカテーテルに巻きつけるように湾曲している請求項16に記載のセンサシステム。
- さらに、前記少なくとも1つのヒドロゲルセンサと通信する電子ユニットを含む請求項12に記載のセンサシステム。
- 前記磁性粒子は前記少なくとも1つのヒドロゲルセンサ内に埋め込まれている請求項12に記載のセンサシステム。
- 前記磁性粒子は前記少なくとも1つのヒドロゲルセンサ上の1層である請求項12に記載のセンサシステム。
- 前記少なくとも1つのヒドロゲルセンサは、アナライトに感受性である請求項12に記載のセンサシステム。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361851603P | 2013-03-11 | 2013-03-11 | |
US61/851,603 | 2013-03-11 | ||
US201461927683P | 2014-01-15 | 2014-01-15 | |
US61/927,683 | 2014-01-15 | ||
PCT/US2014/023352 WO2014164731A1 (en) | 2013-03-11 | 2014-03-11 | Sensor systems |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016517306A true JP2016517306A (ja) | 2016-06-16 |
JP6410789B2 JP6410789B2 (ja) | 2018-10-24 |
Family
ID=51658956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016501210A Active JP6410789B2 (ja) | 2013-03-11 | 2014-03-11 | センサシステム |
Country Status (8)
Country | Link |
---|---|
US (2) | US10448895B2 (ja) |
EP (1) | EP2967414B1 (ja) |
JP (1) | JP6410789B2 (ja) |
KR (1) | KR102242947B1 (ja) |
CN (1) | CN105246401B (ja) |
BR (1) | BR112015022057B1 (ja) |
RU (1) | RU2670660C9 (ja) |
WO (1) | WO2014164731A1 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014164731A1 (en) | 2013-03-11 | 2014-10-09 | University Of Utah Research Foundation | Sensor systems |
US9976974B2 (en) | 2015-01-27 | 2018-05-22 | University Of Utah Research Foundation | Osmolarity-responsive hydrogel sensors and method of use |
BR112019000748A2 (pt) * | 2016-07-28 | 2019-04-24 | Medisieve Ltd | método e misturador magnético |
KR101768648B1 (ko) * | 2016-07-29 | 2017-08-17 | 서울대학교 산학협력단 | 이온성 터치 패널 |
US11980498B2 (en) * | 2016-09-02 | 2024-05-14 | University Of Utah Research Foundation | Implantable and biodegradable smart hydrogel micromechanical resonators with ultrasound readout for biomedical sensing |
EP3506831A4 (en) | 2016-09-02 | 2020-07-29 | University of Utah Research Foundation | ULTRASOUND IMAGING FOR BIOMARKER-SENSITIVE HYDROGELS |
US20200093408A1 (en) * | 2017-06-12 | 2020-03-26 | Florian Solzbacker | Systems, methods, and sensor devices for measuring changes in analyte-sensitive hydrogels |
US11931138B2 (en) * | 2017-12-14 | 2024-03-19 | Applied Biosensors, LLC | Hydrogel sensor assembly |
CN109603942B (zh) * | 2019-02-15 | 2021-12-24 | 京东方科技集团股份有限公司 | 微流控装置和微流控方法 |
CN109998561B (zh) * | 2019-05-15 | 2022-01-28 | 广西中医药大学附属瑞康医院 | 一次性凝血真空采血管 |
JP2022547189A (ja) | 2019-09-09 | 2022-11-10 | マグニシティ リミテッド | デジタル磁力計を用いた可撓性カテーテルの磁気追跡システムおよび方法 |
CN111543961B (zh) * | 2020-05-11 | 2021-03-09 | 清华大学 | 无线柔性贴片式温度传感器及其制备方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10151115A (ja) * | 1996-11-25 | 1998-06-09 | Dainippon Printing Co Ltd | カテーテル及びその製造方法 |
JPH1156825A (ja) * | 1993-06-30 | 1999-03-02 | Biomedical Sensors Ltd | 複数パラメータカテーテル並びにパラメータ測定装置 |
JP2009520976A (ja) * | 2005-12-21 | 2009-05-28 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 磁気化学センサ |
JP2009521705A (ja) * | 2005-12-27 | 2009-06-04 | バイエル・ヘルスケア・エルエルシー | 少なくとも一つの電極を有する基板を用いる電気化学センサーシステム及び同システムの形成方法 |
JP2009204334A (ja) * | 2008-02-26 | 2009-09-10 | Canon Inc | 磁気バイオセンサーを利用した標的物質検出方法及びキット |
JP2009276089A (ja) * | 2008-05-12 | 2009-11-26 | Canon Inc | 液体組成物の攪拌方法、検出方法及び検出キット |
JP2011508213A (ja) * | 2007-12-21 | 2011-03-10 | ティツー・バイオシステムズ・インコーポレーテッド | 埋め込み可能な構成品を備えた磁気共鳴システムおよびその使用方法 |
JP2011523704A (ja) * | 2008-05-20 | 2011-08-18 | カンタイマー,インコーポレイティド | イオン交換によって生体液試料を分析するための方法、システム、及び装置 |
US20110275985A1 (en) * | 2008-07-03 | 2011-11-10 | T2 Biosystems, Inc. | Magnetic nanosensor compositions and bioanalytical assays therefor |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3674012A (en) | 1970-04-17 | 1972-07-04 | American Optical Corp | Blood coagulation detection device |
US3841307A (en) | 1972-11-15 | 1974-10-15 | P Friedell | Subepidermal cannular instrument and method for automated determination of bleeding time and blood loss |
US4949722A (en) | 1989-09-18 | 1990-08-21 | Roy Bean | Method for determining blood platelet adhesiveness |
CA2080224A1 (en) | 1990-04-18 | 1991-10-19 | Jindrich Kopecek | Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting ph-dependent swelling |
RU2103915C1 (ru) * | 1990-07-09 | 1998-02-10 | Естественно-научный институт при Пермском государственном университете им.А.М.Горького | Зонд для исследования желудочно-кишечного тракта |
US5447727A (en) | 1992-10-14 | 1995-09-05 | The Dow Chemical Company | Water-absorbent polymer having improved properties |
NO925047L (no) | 1992-12-30 | 1994-07-01 | Hafslund Nycomed As | Anordning og anvendelse av anordningen til måling av tendens til blodproppdannelse |
US5427144A (en) | 1994-02-24 | 1995-06-27 | Deumed Group Inc. | Valve means with fluid retraction means |
US6615071B1 (en) | 1995-09-20 | 2003-09-02 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
US6753191B2 (en) | 1996-11-06 | 2004-06-22 | University Of Pittsburgh | Polymerized crystalline colloidal array chemical sensing materials for use in high ionic strength solutions |
AU9599498A (en) | 1997-09-30 | 1999-04-23 | M-Biotech, Inc. | Biosensor |
US6464699B1 (en) | 1997-10-10 | 2002-10-15 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same |
DE19811017A1 (de) | 1998-03-13 | 1999-09-16 | Dade Behring Marburg Gmbh | Neues Verfahren zur Bestimmung von Plasmaproteinen und Faktoren der Hämostase sowie ein neues, implantierbares Meßgerät |
US7179487B1 (en) | 1998-06-19 | 2007-02-20 | University Of Utah Research Foundation | Hydrogels of water soluble polymers crosslinked by protein domains |
US6146327A (en) | 1998-08-04 | 2000-11-14 | Wilk; Peter J. | Method for in vivo measurement of coagulation rate |
CN1275149A (zh) | 1998-08-13 | 2000-11-29 | 株式会社日本触媒 | 水溶胀***联聚合物组合物及其制备方法 |
US6475750B1 (en) | 1999-05-11 | 2002-11-05 | M-Biotech, Inc. | Glucose biosensor |
US6835553B2 (en) | 1999-05-11 | 2004-12-28 | M-Biotech, Inc. | Photometric glucose measurement system using glucose-sensitive hydrogel |
US6514689B2 (en) | 1999-05-11 | 2003-02-04 | M-Biotech, Inc. | Hydrogel biosensor |
NL1012223C2 (nl) | 1999-06-03 | 2000-12-06 | Martil Instr B V | Hartgangmaker alsmede gangmakereenheid en elektrische draad daarvoor. |
CN1254284C (zh) | 1999-10-22 | 2006-05-03 | 生物协同作用公司 | 在导管内贮存和释放物质的装置和方法 |
US6442413B1 (en) * | 2000-05-15 | 2002-08-27 | James H. Silver | Implantable sensor |
US7625951B2 (en) | 2000-07-13 | 2009-12-01 | University Of Kentucky Research Foundation | Stimuli-responsive hydrogel microdomes integrated with genetically engineered proteins for high-throughput screening of pharmaceuticals |
US7262063B2 (en) * | 2001-06-21 | 2007-08-28 | Bio Array Solutions, Ltd. | Directed assembly of functional heterostructures |
AUPR808001A0 (en) | 2001-10-05 | 2001-10-25 | Ragless, Clive Lindsay | Method and apparatus for determining concentration of a chemical substance in a solution |
WO2003051286A2 (en) | 2001-11-01 | 2003-06-26 | Regents Of The University Of Minnesota | Hydrogel compositions, devices, and microscale components |
JP3943955B2 (ja) | 2002-02-25 | 2007-07-11 | 株式会社タニタ | 深部静脈血栓症判定装置 |
US6848384B2 (en) | 2002-03-13 | 2005-02-01 | John Andrew Higgins | Knuckle |
US7150975B2 (en) | 2002-08-19 | 2006-12-19 | Animas Technologies, Llc | Hydrogel composition for measuring glucose flux |
US8545830B2 (en) | 2003-03-24 | 2013-10-01 | University Of Tennessee Research Foundation | Multi-functional polymeric materials and their uses |
CA2522755A1 (en) | 2003-04-16 | 2004-11-04 | Drexel University | Acoustic blood analyzer for assessing blood properties |
US7473548B2 (en) | 2003-04-25 | 2009-01-06 | Medtronic, Inc. | Optical detector for enzyme activation |
DE602004016310D1 (de) | 2003-04-25 | 2008-10-16 | Cook Inc | Abgabekatheter |
US8324184B2 (en) | 2003-05-15 | 2012-12-04 | University Of Utah Research Foundation | Anti-adhesion composites and methods of use thereof |
US20050033136A1 (en) * | 2003-08-01 | 2005-02-10 | Assaf Govari | Catheter with electrode strip |
US7892188B2 (en) | 2003-10-22 | 2011-02-22 | Hemosonics, Llc | Method and apparatus for characterization of clot formation |
WO2005072334A2 (en) | 2004-01-23 | 2005-08-11 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Photoresponsive hydrogels |
US7884185B2 (en) | 2004-07-28 | 2011-02-08 | University Of Delaware | Hydrogels and uses thereof |
US8224414B2 (en) | 2004-10-28 | 2012-07-17 | Echo Therapeutics, Inc. | System and method for analyte sampling and analysis with hydrogel |
US20060239986A1 (en) | 2005-01-26 | 2006-10-26 | Perez-Luna Victor H | Method for the formation of hydrogel multilayers through surface initiated photopolymerization |
EP1851268A4 (en) | 2005-02-23 | 2011-02-16 | Univ California | FLEXIBLE, FUNCTIONAL COMPOSITES ON HYDROGEL BASE |
WO2006127865A2 (en) | 2005-05-24 | 2006-11-30 | Georgia Tech Research Corporation | Bioresponsive hydrogels |
US20080188928A1 (en) | 2005-09-16 | 2008-08-07 | Amr Salahieh | Medical device delivery sheath |
CA2562580C (en) * | 2005-10-07 | 2014-04-29 | Inrad, Inc. | Drug-eluting tissue marker |
US20120035540A1 (en) | 2006-04-12 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Event-based control of a lumen traveling device |
US20120035434A1 (en) | 2006-04-12 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Control of a lumen traveling device in a body tube tree |
US20100285094A1 (en) | 2006-04-20 | 2010-11-11 | University Of Utah Research Foundation | Polymeric compositions and methods of making and using thereof |
US8747870B2 (en) | 2006-04-20 | 2014-06-10 | University Of Utah Research Foundation | Polymeric compositions and methods of making and using thereof |
US8382987B2 (en) | 2006-09-27 | 2013-02-26 | Alessandra Luchini | Method for harvesting nanoparticles and sequestering biomarkers |
RU2009117658A (ru) * | 2006-10-12 | 2010-11-20 | Конинклейке Филипс Электроникс Н.В. (Nl) | Обнаружение состояния среды полностью интегральным преобразовательным устройством на основе гидрогеля |
JP2010508056A (ja) | 2006-10-30 | 2010-03-18 | エルフィ−テック リミテッド | 生物学的パラメータの体内での測定のためのシステム及び方法 |
US8265745B2 (en) | 2006-12-29 | 2012-09-11 | St. Jude Medical, Atrial Fibillation Division, Inc. | Contact sensor and sheath exit sensor |
WO2008135916A1 (en) * | 2007-05-03 | 2008-11-13 | Koninklijke Philips Electronics N.V. | Magnetochemical sensor |
US8328720B2 (en) | 2007-08-10 | 2012-12-11 | Infotonics Technology Center, Inc. | MEMS interstitial prothrombin time test |
US20090105799A1 (en) | 2007-10-23 | 2009-04-23 | Flowmedica, Inc. | Renal assessment systems and methods |
US20090170209A1 (en) | 2007-12-29 | 2009-07-02 | Music Germlin, Inc | Hydrogel chemical sensor |
US8283384B2 (en) | 2008-01-24 | 2012-10-09 | University Of Utah Research Foundation | Adhesive complex coacervates and methods of making and using thereof |
JP5739668B2 (ja) | 2008-02-13 | 2015-06-24 | ハイパーブランチ メディカル テクノロジー, インコーポレイテッド | 調節可能な分解速度を有する架橋ポリアルキレンイミンヒドロゲル |
US20090240121A1 (en) | 2008-03-21 | 2009-09-24 | Nova Biomedical Corporation | Intravascular sensor and insertion set combination |
WO2010087912A1 (en) | 2009-01-30 | 2010-08-05 | University Of Utah Research Foundation | Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof |
US8317737B2 (en) | 2009-02-25 | 2012-11-27 | The Invention Science Fund I, Llc | Device for actively removing a target component from blood or lymph of a vertebrate subject |
US8708907B2 (en) | 2009-05-06 | 2014-04-29 | Elfi-Tech | Method and apparatus for determining one or more blood parameters from analog electrical signals |
US8283398B2 (en) * | 2009-07-29 | 2012-10-09 | Xerox Corporation | Polyhedral silsesquioxane modified polyimide containing intermediate transfer members |
US20110053173A1 (en) | 2009-08-28 | 2011-03-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Game with detection capability |
US8810417B2 (en) | 2009-08-28 | 2014-08-19 | The Invention Science Fund I, Llc | Beverage immersate with detection capability |
EP2818198B1 (en) * | 2009-10-02 | 2020-11-25 | Medtronic Xomed, Inc. | Endotracheal tube apparatus |
WO2011066718A1 (en) | 2009-12-01 | 2011-06-09 | The Hong Kong University Of Science And Technology | Compositions containing thermally-induced self-assembly of nonionic surfactants and their application in smart glass technologies |
EP2523656A4 (en) | 2010-01-15 | 2013-12-11 | Univ Utah Res Found | NETWORKED HYDROGELES AND METHOD FOR THEIR MANUFACTURE AND USE |
US9500186B2 (en) | 2010-02-01 | 2016-11-22 | Medipacs, Inc. | High surface area polymer actuator with gas mitigating components |
US20130143821A1 (en) | 2010-02-04 | 2013-06-06 | University Of Tennessee Research Foundation | Hydrophobically-modified hyaluronan and methods of making and using thereof |
US8999916B2 (en) | 2010-03-31 | 2015-04-07 | Agency For Science, Technology And Research | Crosslinked peptide hydrogels |
EP2433562B1 (de) | 2010-09-28 | 2014-07-09 | BIOTRONIK SE & Co. KG | Medizinisches Sensorsystem zum Nachweis von zumindest einem Merkmal in zumindest einem tierischen und/oder menschlichen Körper |
US8663563B2 (en) | 2010-12-03 | 2014-03-04 | Purdue Research Foundation | Reflective diffractometric hydrogel sensor for biological and chemical detection |
US9375179B2 (en) * | 2010-12-23 | 2016-06-28 | Biosense Webster, Inc. | Single radio-transparent connector for multi-functional reference patch |
US8792962B2 (en) | 2010-12-30 | 2014-07-29 | Biosense Webster, Inc. | Catheter with single axial sensors |
WO2012101644A2 (en) | 2011-01-28 | 2012-08-02 | Bar Ilan University | Method and system for non-invasively monitoring biological or biochemical parameters of individual |
WO2012170401A2 (en) | 2011-06-06 | 2012-12-13 | Percuvision, Llc | Sensing catheter emitting radiant energy |
US9737244B2 (en) * | 2012-03-13 | 2017-08-22 | Purdue Research Foundation | Sensor having ferrogel with magnetic particles |
WO2014164731A1 (en) | 2013-03-11 | 2014-10-09 | University Of Utah Research Foundation | Sensor systems |
-
2014
- 2014-03-11 WO PCT/US2014/023352 patent/WO2014164731A1/en active Application Filing
- 2014-03-11 US US14/774,070 patent/US10448895B2/en active Active
- 2014-03-11 EP EP14780278.9A patent/EP2967414B1/en active Active
- 2014-03-11 KR KR1020157024727A patent/KR102242947B1/ko active IP Right Grant
- 2014-03-11 JP JP2016501210A patent/JP6410789B2/ja active Active
- 2014-03-11 BR BR112015022057-6A patent/BR112015022057B1/pt active IP Right Grant
- 2014-03-11 RU RU2015138942A patent/RU2670660C9/ru active
- 2014-03-11 CN CN201480013762.3A patent/CN105246401B/zh active Active
-
2019
- 2019-06-21 US US16/449,169 patent/US20190313977A1/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1156825A (ja) * | 1993-06-30 | 1999-03-02 | Biomedical Sensors Ltd | 複数パラメータカテーテル並びにパラメータ測定装置 |
JPH10151115A (ja) * | 1996-11-25 | 1998-06-09 | Dainippon Printing Co Ltd | カテーテル及びその製造方法 |
JP2009520976A (ja) * | 2005-12-21 | 2009-05-28 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 磁気化学センサ |
JP2009521705A (ja) * | 2005-12-27 | 2009-06-04 | バイエル・ヘルスケア・エルエルシー | 少なくとも一つの電極を有する基板を用いる電気化学センサーシステム及び同システムの形成方法 |
JP2011508213A (ja) * | 2007-12-21 | 2011-03-10 | ティツー・バイオシステムズ・インコーポレーテッド | 埋め込み可能な構成品を備えた磁気共鳴システムおよびその使用方法 |
JP2009204334A (ja) * | 2008-02-26 | 2009-09-10 | Canon Inc | 磁気バイオセンサーを利用した標的物質検出方法及びキット |
JP2009276089A (ja) * | 2008-05-12 | 2009-11-26 | Canon Inc | 液体組成物の攪拌方法、検出方法及び検出キット |
JP2011523704A (ja) * | 2008-05-20 | 2011-08-18 | カンタイマー,インコーポレイティド | イオン交換によって生体液試料を分析するための方法、システム、及び装置 |
US20110275985A1 (en) * | 2008-07-03 | 2011-11-10 | T2 Biosystems, Inc. | Magnetic nanosensor compositions and bioanalytical assays therefor |
Also Published As
Publication number | Publication date |
---|---|
US20160015323A1 (en) | 2016-01-21 |
JP6410789B2 (ja) | 2018-10-24 |
CN105246401B (zh) | 2019-11-22 |
US20190313977A1 (en) | 2019-10-17 |
BR112015022057B1 (pt) | 2022-06-28 |
CN105246401A (zh) | 2016-01-13 |
EP2967414A1 (en) | 2016-01-20 |
RU2015138942A (ru) | 2017-04-17 |
RU2670660C2 (ru) | 2018-10-24 |
BR112015022057A2 (pt) | 2017-07-18 |
RU2670660C9 (ru) | 2018-12-12 |
KR102242947B1 (ko) | 2021-04-22 |
EP2967414B1 (en) | 2019-12-18 |
US10448895B2 (en) | 2019-10-22 |
KR20150143432A (ko) | 2015-12-23 |
EP2967414A4 (en) | 2017-02-22 |
WO2014164731A1 (en) | 2014-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6410789B2 (ja) | センサシステム | |
JP6744019B2 (ja) | 生物流体の表皮特性評価のためのデバイス及び関連する方法 | |
US10058276B2 (en) | MEMS affinity sensor for continuous monitoring of analytes | |
US9737244B2 (en) | Sensor having ferrogel with magnetic particles | |
Korostynska et al. | Materials and techniques for in vivo pH monitoring | |
US20150056643A1 (en) | Microfluidic devices for measuring platelet coagulation and associated systems and methods | |
Zhou et al. | Biomedical sensor, device and measurement systems | |
US20200093408A1 (en) | Systems, methods, and sensor devices for measuring changes in analyte-sensitive hydrogels | |
US20160061814A1 (en) | Microfluidic devices for measuring platelet coagulation and associated systems and methods | |
Gil et al. | Smart implanted access port catheter for therapy intervention with pH and lactate biosensors | |
Neuman | Biomedical sensors | |
Jamal et al. | Sensor and biosensor to detect vascular graft infection: diagnosis and challenges | |
dos Santos et al. | Biosensors | |
Omidian et al. | Hydrogels in biosensing and medical diagnostics | |
Yamada et al. | Detection and estimation of low-concentration magnetic fluid inside body by a needle-type GMR sensor | |
Wan et al. | Millimeter-scale magnetic implants paired with a fully integrated wearable device for wireless biophysical and biochemical sensing | |
Sonkusale et al. | Sensors and Platforms for Flexible Bioelectronics | |
Park | Wireless chemical sensing schemes using environmentally sensitive hydrogels | |
Naegele et al. | Integration of a silicon sensor for application in biomedical analytics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171218 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20171220 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180314 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180827 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180925 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6410789 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |